Novonesis (Novozymes) B/ DK0060336014 /
2024-06-06 11:30:01 AM | Chg. +3.55 | Volume | Bid11:30:01 AM | Ask2024-06-06 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
422.75DKK | +0.85% | 108,863 Turnover: 19.52 mill. |
422.70Bid Size: 44 | 422.90Ask Size: 213 | 117.74 bill.DKK | 1.42% | 31.78 |
Fundamentals
FY 2022 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 13.29 DKK | 17.40% |
EPS Diluted: | - DKK | 17.45% |
Revenues per Share: | 62.97 DKK | -3.86% |
Book Value per Share: | 49.64 DKK | -4.19% |
Cash Flow per Share: | 14.37 DKK | -19.24% |
Dividend per Share: | 6.00 DKK | 9.09% |
Total | in mill. | |
Revenues: | 17,553.00 DKK | 17.40% |
Net Income: | 3,686.00 DKK | 17.20% |
Operating Cash Flow: | 4,006.00 DKK | - |
Cash and Cash Equivalents: | 1,041.00 DKK | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 31.78 | 26.48 |
P/S Ratio: | 6.71 | 5.59 |
P/BV ratio: | 8.51 | 7.09 |
P/CF Ratio: | 29.39 | 24.48 |
PEG: | 1.83 | 1.52 |
Earnings Yield: | 3.15% | 3.78% |
Dividend Yield: | 1.42% | 1.71% |
Market Capitalization | ||
Market Capitalization: | 117.74 bill. DKK | 98.09 bill. DKK |
Free Float Market Cap.: | - DKK | - DKK |
Market Cap. / Employee: | 17.36 mill. DKK | 14.46 mill. DKK |
Shares Outstanding: | 278.73 mill. |
Profitability
Gross Profit Margin: | 54.56% |
EBIT Margin: | 25.98% |
Net Profit Margin: | 21.00% |
Return on Equity: | 26.64% |
Return on Assets: | 13.17% |
Financial Strength
Liquidity I / Cash Ratio: | 14.95% |
Liquidity II / Quick Ratio: | 64.56% |
Liquidity III / Current Ratio: | 132.72% |
Debt / Equity Ratio: | 102.23% |
Dynam. Debt / Equity Ratio: | 353.12% |
Efficiency
Employees: | 6,781 |
Personal Expenses / Employee: | - DKK |
Revenues / Employee: | 2,588,556.26 DKK |
Net Income / Employee: | 543,577.64 DKK |
Total Assets / Employee: | 4,126,677.48 DKK |
* Fiscal Year End: | 2022-12-31 |
Accounting Standard: | IFRS |
Currency: | DKK |